Biliary Tract Neoplasms Clinical Trials

7 recruiting

Biliary Tract Neoplasms Trials at a Glance

9 actively recruiting trials for biliary tract neoplasms are listed on ClinicalTrialsFinder across 6 cities in 7 countries. The largest study group is Phase 2 with 5 trials, with the heaviest enrollment activity in Beijing, Amiens, and Angers. Lead sponsors running biliary tract neoplasms studies include Hospital Universitari de Bellvitge, Peking Union Medical College Hospital, and Instituto do Cancer do Estado de São Paulo.

Browse biliary tract neoplasms trials by phase

Treatments under study

About Biliary Tract Neoplasms Clinical Trials

Looking for clinical trials for Biliary Tract Neoplasms? There are currently 7 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Biliary Tract Neoplasms trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Biliary Tract Neoplasms clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 19 of 9 trials

Recruiting
Phase 2

Agnostic Therapy in Rare Solid Tumors

Cancer of Unknown PrimarySoft Tissue SarcomaCholangiocarcinoma+38 more
Instituto do Cancer do Estado de São Paulo28 enrolled8 locationsNCT06638931
Recruiting

Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma

Stomach NeoplasmsMesotheliomaPancreatic Neoplasms+2 more
National Cancer Institute (NCI)1,000 enrolled1 locationNCT01950572
Recruiting
Phase 2

Trifluridine/Tipiracil + Oxaliplatin in Participants With Advanced or Metastatic Biliary Tract Cancer

Biliary Tract CancerCholangiocarcinomaGallbladder Cancer+2 more
Case Comprehensive Cancer Center27 enrolled2 locationsNCT07146646
Recruiting
Phase 2

Pembrolizumab With or Without Lenvatinib or Chemotherapy in First-Line Treatment of Advanced Biliary Tract Cancer

Biliary Tract Neoplasms Immunotherapy
Peking Union Medical College Hospital60 enrolled1 locationNCT06230471
Recruiting
Not Applicable

EUS-Gallbladder vs CDS as First Line in MBDO- Palliative (CARPEGIEM Trial)

Biliary Tract NeoplasmsPancreatic Cancer Non-resectableMalignant Biliary Obstruction
Hospital Universitari de Bellvitge128 enrolled10 locationsNCT06375967
Recruiting
Not Applicable

EUS-guided Choledochoduodenostomy vs ERCP as First Line in Malignant Distal Obstruction (CARPEDIEM Trial)

Pancreatic CancerBiliary Tract NeoplasmsMalignant Biliary Obstruction
Hospital Universitari de Bellvitge120 enrolled10 locationsNCT06653192
Recruiting
Phase 2

Adoptive Transfer of Tumor Infiltrating Lymphocytes for Biliary Tract Cancers

Biliary Tract CancerCholangiocarcinomaBiliary Tract Neoplasms
Udai Kammula59 enrolled1 locationNCT03801083
Recruiting
Phase 3

Personalized Medicine for Advanced Biliary Cancer Patients

Biliary Tract Neoplasms
UNICANCER800 enrolled69 locationsNCT05615818
Recruiting
Phase 2

Toripalimab With or Without Lenvatinib or Chemotherapy in First-Line Treatment of Advanced Biliary Tract Cancer

Biliary Tract Neoplasms Immunotherapy
Peking Union Medical College Hospital300 enrolled1 locationNCT06362317